BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy (Q97520951)

From Wikidata
Jump to navigation Jump to search
scientific article published on 08 July 2020
edit
Language Label Description Also known as
English
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
scientific article published on 08 July 2020

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit